TNDM Stock Analysis: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$18.61
-0.20 (-1.06%)
▼
5d:
-20.2%
30d:
-20.5%
90d:
-15.33%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 29, 2026
25d
Smart Money Accumulation
TNDM is down 22.5% this week, but smart money is accumulating calls. Top strike: $25 2026-05-15 with 418 OI. Call ratio: 76% View Scanner →
Strength: 10.0/10
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TNDM is down 20.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TNDM is down 20.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $18.61, which is considered oversold relative to its 30-day fair value range of $20.92 to $25.56.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $18.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.76 (+65.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $18.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.76 (+65.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$20.92 -
$25.56
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.3% below Wall St target ($30.76)
- WARNING: Recommendation downgraded due to -20.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$20.92 -
$25.56
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$18.08
Resistance Level
$26.38
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-984.66
Wall Street Target
$30.76
(+65.3%)
Revenue Growth (YoY)
2.7%
Earnings Growth (YoY)
-37.0%
Profit Margin
-20.2%
Share & Embed Analysis
Last updated: April 03, 2026 4:59 AM ET
Data refreshes hourly during market hours. Next update: 5:59 AM
Data refreshes hourly during market hours. Next update: 5:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark David Novara
SELL
187 shares
2026-03-17
Mark David Novara
SELL
2 shares
2026-03-05
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
